CISNE or MASCC, which predictor is really the weakest in febrile neutropenia?
Eur J Intern Med
.
2018 Apr:50:e33-e34.
doi: 10.1016/j.ejim.2017.11.009.
Epub 2017 Nov 20.
Authors
A Carmona-Bayonas
1
,
P Jiménez-Fonseca
2
Affiliations
1
Hematology & Medical Oncology Department, Hospital Universitario Morales Meseguer, Murcia, Spain. Electronic address:
[email protected]
.
2
Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
PMID:
29157884
DOI:
10.1016/j.ejim.2017.11.009
No abstract available
Keywords:
CISNE; Complications; Febrile neutropenia; MASCC; Risk.
Publication types
Letter
Comment
MeSH terms
Antineoplastic Agents
Febrile Neutropenia*
Fever
Humans
Neoplasms*
Substances
Antineoplastic Agents